Keywords: LDL-Aphrase; FH; Early treatment; LDL-apheresis; Lp(a);
مقالات ISI LDL-Aphrase (ترجمه نشده)
مقالات زیر هنوز به فارسی ترجمه نشده اند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
در صورتی که به ترجمه آماده هر یک از مقالات زیر نیاز داشته باشید، می توانید سفارش دهید تا مترجمان با تجربه این مجموعه در اسرع وقت آن را برای شما ترجمه نمایند.
Transition from LDL apheresis to evolocumab in heterozygous FH is equally effective in lowering LDL, without lowering HDL cholesterol
Keywords: LDL-Aphrase; Familial hypercholesterolemia; LDL-apheresis; PCSK9 inhibitors;
LDL-apheresis contributes to survival extension and renal function maintenance of severe diabetic nephropathy patients: A retrospective analysis
Keywords: LDL-Aphrase; LDL-apheresis; Diabetic nephropathy; Nephrotic syndrome; Retrospective study;
Elevated serum MMP-9/TIMP-1 ratio in patients with homozygous familial hypercholesterolemia: Effects of LDL-apheresis
Keywords: LDL-Aphrase; LDL cholesterol; LDL-apheresis; Inflammation; Plaque instability; Cardiovascular disease;
Emerging low-density lipoprotein (LDL) therapies: Management of severely elevated LDL cholesterol-The role of LDL-apheresis
Keywords: LDL-Aphrase; Coronary heart disease; Familial hypercholesterolemia; LDL-apheresis; Low-density lipoprotein cholesterol;
The decrease of mean platelet volume after extracorporeal LDL-cholesterol elimination
Keywords: LDL-Aphrase; Mean platelet volume; Familial hyperlipoproteinemia; LDL-apheresis; Extracorporeal elimination; Therapeutic hemapheresis; Rheohemapheresis
Early-onset plasmapheresis and LDL-apheresis provide better disease control for pediatric homozygous familial hypercholesterolemia than HMG-CoA reductase inhibitors and ameliorate atherosclerosis
Keywords: LDL-Aphrase; Plasmapheresis; LDL-apheresis; Children; Familial hypercholesterolemia
L'hypercholestérolémie familiale homozygote : comparaison de trois techniques de LDL-aphérèse
Keywords: LDL-Aphrase; Hypercholestérolémie familiale homozygote; LDL-aphérèse; LDL cholestérol; Traitement; Homozygous familial hypercholesterolemia; LDL-apheresis; LDL; Cholesterol; Treatment;
Effects of selective H.E.L.P. LDL-apheresis on plasma inflammatory markers concentration in severe dyslipidemia: Implication for anti-inflammatory response
Keywords: LDL-Aphrase; Heparin-induced Extracorporeal LDL precipitation; LDL-apheresis; Inflammation; Cytokines; Atherosclerosis;
Cytokines profile in serum of homozygous familial hypercholesterolemia is changed by LDL-apheresis
Keywords: LDL-Aphrase; Inflammation; Atherosclerosis; Cytokines; Homozygous familial hypercholesterolemia; LDL-apheresis;
Apheresis-inducible cytokine pattern change in severe, genetic dyslipidemias
Keywords: LDL-Aphrase; Cytokines; Familial hypercholesterolemia; HyperLp(a)lipoproteinemia; LDL-apheresis; Inflammation;
Review ArticleLipid and low-density-lipoprotein apheresis. Effects on plasma inflammatory profile and on cytokine pattern in patients with severe dyslipidemia
Keywords: LDL-Aphrase; Lipid-apheresis; LDL-apheresis; Cytokines; Inflammation; Atherosclerosis;
Treatment of symptomatic hyperLp(a)lipidemia with LDL-apheresis vs. usual care
Keywords: LDL-Aphrase; HyperLp(a)lipoproteinemia; LDL-apheresis; Coronary artery disease; Coronary angiography
The first results demonstrating efficiency and safety of a double-column whole blood method of LDL-apheresis
Keywords: LDL-Aphrase; LDL-apheresis; Whole Blood method; Adsorption of lipoproteins; LDL-C
WAA apheresis registry in the Czech Republic: Two centers experience
Keywords: LDL-Aphrase; Therapeutic apheresis; Apheresis registry; Adverse events; Quality assurance; Plasma exchange; LDL-apheresis;
26 Years of LDL – Apheresis: A review of experience
Keywords: LDL-Aphrase; LDL-Apheresis; LDL-elimination; Apheresis therapy; Cholesterol; Cholesterol lowering therapy; LDL-cholesterol; Familial hypercholesterolaemia
Elevated serum soluble endoglin (sCD105) decreased during extracorporeal elimination therapy for familial hypercholesterolemia
Keywords: LDL-Aphrase; Endoglin; Familial hyperlipoproteinemia; LDL-apheresis; Extracorporeal elimination; Therapeutic hemapheresis
The effect of ezetimibe on serum lipids and lipoproteins in patients with homozygous familial hypercholesterolemia undergoing LDL-apheresis therapy
Keywords: LDL-Aphrase; LDL-apheresis; Homozygous familial hypercholesterolemia; Ezetimibe; Treatment of hyperlipidemia; Combination therapy of familial hypercholesterolemia
Importancia de la aféresis terapéutica en la especialidad de nefrologÃa
Keywords: LDL-Aphrase; Aféresis terapéutica; Plasmaféresis o intercambio de plasma; Inmunoadsorción; Aféresis LDL; Diálisis de albúmina hepática (MARS, Prometheus); Leucocitoaféresis; Hemodiálisis; Therapeutic Apheresis; Plasmapheresis or Plasma exchange; Immunoadsorp
Quo vadis haemapheresis : Current developments in haemapheresis
Keywords: LDL-Aphrase; Apheresis history; Cytapheresis; Cell therapy; Stem cells; Photopheresis; Rheohaemapheresis; Sepsis therapy; LDL-apheresis; Lp(a)-apheresis
Effects of ezetimibe on plasma lipoproteins in severely hypercholesterolemic patients treated with regular LDL-apheresis and statins
Keywords: LDL-Aphrase; Ezetimibe; Cholesterol absorption inhibitor; LDL-apheresis; Apheresis; LDL-cholesterol; Statins; HMG CoA reductase inhibitors; Hyperlipoproteinemia;
Optimization of the therapeutic procedure during LDL-apheresis-a computerized model
Keywords: LDL-Aphrase; LDL-apheresis; Familial hypercholesterolemia; Atherosclerosis; Immunoadsorption;